-
Mashup Score: 0FDA OKs Expanded MRI Labeling for Eterna SCS for Pain - 12 month(s) ago
Expanded labeling applies to MR condition leads, allowing for higher quality scan images for patients with chronic pain.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0FDA OKs New Drug for Hot Flashes - 12 month(s) ago
The first-in-class approval of fezolinetant (Veozah) is for treatment of moderate to severe vasomotor symptoms associated with menopause.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#FDAapproves fezolinetant, an oral medication for the treatment of moderate to severe #hotflashes in menopausal women. #menopause #womenshealth https://t.co/yRvRQb161P
-
-
Mashup Score: 0FDA OKs New Drug for Fabry Disease - 12 month(s) ago
Pegunigalsidase alfa (Elfabrio) is an intravenously administered enzyme replacement therapy to treat adults with confirmed Fabry disease.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#FDAapproves pegunigalsidase alfa, an enzyme replacement therapy to treat adults with confirmed #Fabrydisease. https://t.co/YHm2kUlkKe
-
-
Mashup Score: 0FDA Gives Fast-Track Approval to New ALS Drug - 1 year(s) ago
The FDA fast-tracked the approval on the basis of early trial results.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#FDAapproves drug for rare form of ALS https://t.co/6JdCa8A1HA
-
-
Mashup Score: 0FDA Approves New Merkel Cell Carcinoma Drug Zynyz - 1 year(s) ago
The PD-1 inhibitor received accelerated approval for adults with metastatic or recurrent locally advanced Merkel cell carcinoma.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
FDA approves new Merkel cell carcinoma drug zynyz. https://t.co/4GsDemFlCK #MedTwitter #FDAapproves #FDAAlert #OncTwitter
-
-
Mashup Score: 1
FDA advisers on Thursday overwhelmingly backed full approval of Pfizer’s oral antiviral COVID-19 treatment Paxlovid for adults at high risk of progression to severe disease.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
FDA advisers back full approval for pfizer's COVID treatment paxlovid. https://t.co/6jpd4UbuEB #COVID #FDAapproves #medtwitter https://t.co/YXFg1W5r6Z
-
-
Mashup Score: 7Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas - 1 year(s) ago
The targeted therapy combination beat chemotherapy on progression-free survival, but there was no difference in overall survival at the interim analysis.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Dabrafenib-Trametinib combo approved for pediatric gliomas. https://t.co/w0pZCYinLl #FDAapproves #MedTwitter
-
-
Mashup Score: 0FDA OKs First Drug for Rett Syndrome - 1 year(s) ago
Trofinetide (Daybue) is for adults and children aged 2 years and older with Rett syndrome, a rare, genetic neurodevelopmental disorder affecting mostly females.
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
#FDAapproves trofinetide oral solution as the first treatment of Rett syndrome https://t.co/3Od8JgfjSp
-
-
Mashup Score: 0FDA OKs First Drug for Rett Syndrome - 1 year(s) ago
Trofinetide (Daybue) is for adults and children aged 2 years and older with Rett syndrome, a rare, genetic neurodevelopmental disorder affecting mostly females.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#FDAapproves trofinetide oral solution as the first treatment of Rett syndrome. https://t.co/EPND30bWpf
-
-
Mashup Score: 8FDA Approves Zavegepant Nasal Spray for Acute Migraine - 1 year(s) ago
The third-generation CGRP receptor agonist provided relief from acute migraine as soon as 15 minutes after intranasal dosing in a pivotal phase 3 trial.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#FDAapproves zavegepant, the first CGRP receptor antagonist nasal spray for the acute treatment of #migraine. #TwitteRx https://t.co/zutLXdIdWj
-
#FDAapproves zavegepant, the first CGRP receptor antagonist nasal spray for the acute treatment of #migraine. https://t.co/qnJcUDKdAn
-
#FDAapproves expanded MRI labeling for Abbott Laboratories' Eterna spinal cord stimulation system, which will allow for higher-quality scan images for patients with #chronicpain. https://t.co/lst7K2cHqi